EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Miller-Fisher Syndrome: Are Anti-GAD Antibodies Implicated in Its Pathophysiology?

Ioannis E Dagklis iD, Sotirios Papagiannopoulos, Varvara Theodoridou, Dimitrios Kazis iD, Ourania Argyropoulou, Sevasti Bostantjopoulou

Case Reports in Neurological Medicine · 2016 · 2016 · 1-3

DOI: 10.1155/2016/3431849 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Case Reports in Neurological Medicine, 2016. Verfasst von Ioannis E Dagklis und 5 weiteren Autor:innen. Beteiligte Einrichtung: 3rd Department of Neurology, Medical School, Aristotle University of Thessaloniki, 57010 Thessaloniki, Greece. Die Arbeit wurde bisher 9-mal zitiert (Crossref) und nennt 14 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Miller-Fisher syndrome (MFS) is considered as a variant of the Guillain-Barre syndrome (GBS) and its characteristic clinical features are ophthalmoplegia, ataxia, and areflexia. Typically, it is associated with anti-GQ1b antibodies; however, a significant percentage (>10%) of these patients are seronegative. Here, we report a 67-year-old female patient who presented with the typical clinical features of MFS. Workup revealed antibodies against glutamic acid decarboxylase (GAD) in relatively high titers while GQ1b antibodies were negative. Neurological improvement was observed after intravenous gamma globulin and follow-up examinations showed a continuous clinical amelioration with simultaneous decline of anti-GAD levels which finally returned to normal values. This case indicates that anti-GAD antibodies may be associated with a broader clinical spectrum and future studies in GQ1b-seronegative patients could determine ultimately their clinical and pathogenetic significance in this syndrome.

Autor:innen und Institutionen

  • 3rd Department of Neurology, Medical School, Aristotle University of Thessaloniki, 57010 Thessaloniki, Greece.

ORCID-Profile: Ioannis E Dagklis, Dimitrios Kazis

Zitieren

APA

Dagklis, I. E., Papagiannopoulos, S., Theodoridou, V., Kazis, D., Argyropoulou, O., & Bostantjopoulou, S. (2016). Miller-Fisher Syndrome: Are Anti-GAD Antibodies Implicated in Its Pathophysiology?. Case Reports in Neurological Medicine, 2016, 1-3. https://doi.org/10.1155/2016/3431849

Vancouver

Dagklis IE, Papagiannopoulos S, Theodoridou V, Kazis D, Argyropoulou O, Bostantjopoulou S. Miller-Fisher Syndrome: Are Anti-GAD Antibodies Implicated in Its Pathophysiology?. Case Reports in Neurological Medicine. 2016;2016:1-3. doi:10.1155/2016/3431849

BibTeX
@article{Dagklis2016,
  author = {Dagklis, Ioannis E and Papagiannopoulos, Sotirios and Theodoridou, Varvara and Kazis, Dimitrios and Argyropoulou, Ourania and Bostantjopoulou, Sevasti},
  title = {Miller-Fisher Syndrome: Are Anti-GAD Antibodies Implicated in Its Pathophysiology?},
  journal = {Case Reports in Neurological Medicine},
  year = {2016},
  volume = {2016},
  pages = {1--3},
  doi = {10.1155/2016/3431849}
}
Kostenlos starten →